Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/14/26 16:59 | 9/10/26 | LGND | Health | Drug | Pharmaceutical Preparations | Zimmermann Martine | FL | D | 1 | S | -342 | 285.00 | 0 | -1 | 4 | D | ||||||||||||||||
9/8/26 18:34 | 9/3/26 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | 3 | S.d | -3,137 | 209.12 | 0 | -15 | 42 | D | |||||||||||||||
8/14/26 17:05 | 8/12/26 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | 2 | M.d | 11,042 | 174.49 | 0 | 63 | 28 | D | |||||||||||||||
8/14/26 17:05 | 8/12/26 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | 2 | S.d | -11,042 | 174.49 | 0 | -63 | 28 | D | |||||||||||||||
8/14/26 17:04 | 8/12/26 | LGND | Health | Drug | Pharmaceutical Preparations | Haas Jason | FL | D | 2 | M.d | 2,407 | 181.27 | 0 | 13 | 4 | D | ||||||||||||||||
8/14/26 17:04 | 8/12/26 | LGND | Health | Drug | Pharmaceutical Preparations | Haas Jason | FL | D | 2 | S.d | -2,407 | 181.27 | 0 | -13 | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |